Morgan Stanley Investment Management Inc - Net Worth and Insider Trading

Morgan Stanley Investment Management Inc Net Worth

The estimated net worth of Morgan Stanley Investment Management Inc is at least $81 Million dollars as of 2024-11-08. Morgan Stanley Investment Management Inc is the 10% Owner of Sagent Pharmaceuticals Inc and owns about 3,731,293 shares of Sagent Pharmaceuticals Inc (SGNT) stock worth over $81 Million. Details can be seen in Morgan Stanley Investment Management Inc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Morgan Stanley Investment Management Inc has not made any transactions after 2013-10-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Morgan Stanley Investment Management Inc

To

Morgan Stanley Investment Management Inc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Morgan Stanley Investment Management Inc owns 6 companies in total, including Sagent Pharmaceuticals Inc (SGNT) , Morgan Stanley Emerging Markets Fund Inc (MSF) , and Latin American Discovery Fund Inc (LDF) among others .

Click here to see the complete history of Morgan Stanley Investment Management Inc’s form 4 insider trades.

Insider Ownership Summary of Morgan Stanley Investment Management Inc

Ticker Comapny Transaction Date Type of Owner
SGNT Sagent Pharmaceuticals Inc 2015-01-26 10 percent owner
MSF Morgan Stanley Emerging Markets Fund Inc 2004-08-03 other: Investment Adviser
LDF Latin American Discovery Fund Inc 2004-08-03 other: Investment Adviser
LIMIT LIMIT 2004-08-03 other: Investment Adviser
LIMIT LIMIT 2004-08-03 other: Investment Adviser
LIMIT LIMIT 2004-08-03 other: Investment Adviser

Morgan Stanley Investment Management Inc Latest Holdings Summary

Morgan Stanley Investment Management Inc currently owns a total of 1 stock. Morgan Stanley Investment Management Inc owns 3,731,293 shares of Sagent Pharmaceuticals Inc (SGNT) as of October 3, 2013, with a value of $81 Million.

Latest Holdings of Morgan Stanley Investment Management Inc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGNT Sagent Pharmaceuticals Inc 2013-10-03 3,731,293 21.76 81,192,936

Holding Weightings of Morgan Stanley Investment Management Inc


Morgan Stanley Investment Management Inc Form 4 Trading Tracker

According to the SEC Form 4 filings, Morgan Stanley Investment Management Inc has made a total of 0 transactions in Sagent Pharmaceuticals Inc (SGNT) over the past 5 years. The most-recent trade in Sagent Pharmaceuticals Inc is the sale of 47,826 shares on October 3, 2013, which brought Morgan Stanley Investment Management Inc around $969,433.

Insider Trading History of Morgan Stanley Investment Management Inc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Morgan Stanley Investment Management Inc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Morgan Stanley Investment Management Inc Ownership Network

Ownership Network List of Morgan Stanley Investment Management Inc

No Data

Ownership Network Relation of Morgan Stanley Investment Management Inc

Insider Network Chart

Morgan Stanley Investment Management Inc Owned Company Details

What does Sagent Pharmaceuticals Inc do?

Who are the key executives at Sagent Pharmaceuticals Inc?

Morgan Stanley Investment Management Inc is the 10 percent owner of Sagent Pharmaceuticals Inc. Other key executives at Sagent Pharmaceuticals Inc include 10 percent owner Vivo Ventures V, Llc , 10 percent owner Vivo Ventures V Affiliates Fund, L.p. , and 10 percent owner Vivo Ventures Fund V, L.p. .

Sagent Pharmaceuticals Inc (SGNT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sagent Pharmaceuticals Inc (SGNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sagent Pharmaceuticals Inc (SGNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sagent Pharmaceuticals Inc (SGNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sagent Pharmaceuticals Inc Insider Transactions

No Available Data

Morgan Stanley Investment Management Inc Mailing Address

Above is the net worth, insider trading, and ownership report for Morgan Stanley Investment Management Inc. You might contact Morgan Stanley Investment Management Inc via mailing address: 1221 Avenue Of Americas, New York Ny 10020.